Skip to content

Clinical trials

Phase 2 Carcinoma, Ovarian Epithelial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 2 Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20031
20043
20063
20072
20101
20131
20161
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Unknown status3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group9
National Cancer Institute (NCI)4
NCIC Clinical Trials Group3
AltaRex2
University Health Network, Toronto2
Canadian Cancer Trials Group1
Facet Biotech1
Ottawa Regional Cancer Centre1
SWOG Cancer Research Network1
Sunesis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial28
Ovarian Neoplasms21
Fallopian Tube Neoplasms12
Carcinoma1
Melanoma1
Neoplasm Metastasis1
Neoplasms1
Peritoneal Neoplasms1
Pleural Effusion, Malignant1
Recurrence1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.